In a major escalation of the corruption investigation at Tembisa Hospital, the Special Investigating Unit (SIU) has exposed a sophisticated network of 41 suppliers – collectively known as the “Maumela syndicate” – that allegedly secured millions in questionable contracts from the public healthcare facility. SIU head Andy Mothibi revealed that at least three companies within this network are connected to controversial businessman Vusimuzi “Cat” Matlala, while the syndicate’s namesake, Hangwani Maumela – a relative of President Cyril Ramaphosa – has been identified as a central figure in coordinating the suspect deals.
The investigation uncovers how medical supply and service contracts were systematically awarded through processes that bypassed standard procurement regulations, potentially diverting crucial healthcare funds into private hands. For Matlala, this represents another chapter in his extensive history with government contracts, having previously secured substantial agreements across multiple departments despite ongoing legal challenges. The SIU’s findings point to a coordinated effort to exploit hospital procurement systems, raising serious concerns about governance failures within Gauteng’s health administration.
The unit is now preparing to convert these findings into formal action, including civil recovery proceedings to reclaim misappropriated funds and potential criminal referrals for prosecution. The political dimensions of the case are particularly sensitive given Maumela’s familial connection to President Ramaphosa, placing additional pressure on the administration to demonstrate commitment to accountability. This investigation marks a critical test for South Africa’s anti-corruption institutions, highlighting both the persistent vulnerability of public resources to predatory networks and the ongoing struggle to implement effective safeguards in state procurement systems. As the probe advances, it underscores the urgent need for systemic reforms to protect essential services from those seeking to profit at the expense of public health and trust.
